Clinical Trial Update: A Study of Evaluating The Effects Of Pyrotinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pyrotinib after adjuvant trastuzumab in women with early-stage breast cancer is ongoing; no results yet reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pyrotinib (pyrotinib)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN